Basaglar 100 Unit

BASAGLAR 100 Unit is a subcutaneous solution containing insulin glargine, designed for managing blood glucose levels in diabetes. This long-acting insulin helps regulate insulin levels over an extended period.

BASAGLAR 100 Unit is primarily used for the management of diabetes mellitus. It helps control blood sugar levels in adults and children with type 1 and type 2 diabetes. This insulin glargine solution is administered subcutaneously to provide a steady release of insulin throughout the day, supporting glucose regulation.

Common effects of BASAGLAR 100 Unit may include mild redness or itching at the injection site. Some users might experience hypoglycemia, characterized by symptoms such as sweating, dizziness, or shakiness. These effects vary among individuals and typically subside as the body adjusts to the medication.

BASAGLAR 100 Unit should be handled with care to avoid contamination. It is essential to store it properly to maintain its effectiveness. Users should monitor their blood sugar levels regularly and consult a healthcare provider for any concerns. Avoid sharing needles or syringes to prevent infection.

BASAGLAR 100 Unit may interact with other medications, including oral hypoglycemic agents, corticosteroids, and certain antidepressants. Alcohol consumption can also affect blood sugar levels, so it is advisable to monitor intake. Always inform healthcare providers about all medications being taken to avoid potential interactions.